Prognostic Performance of Hematological and Serum Iron and Metabolite Indices for Detection of Early Iron Deficiency

Brian J Sandri1, Jonathan Kim2, Gabriele R Lubach3

  • 1Division of Neonatology, Department of Pediatrics, University of Minnesota, Minneapolis, MN, United States; Masonic Institute for the Developing Brain, University of Minnesota, Minneapolis, MN, United States.

The Journal of Nutrition
|December 10, 2023
PubMed

Insights

Early detection of infant iron deficiency (ID) is crucial. Reticulocyte hemoglobin (RET-He) and specific metabolites like homostachydrine show promise in identifying preanemic ID and predicting brain metabolic dysfunction in infants.

Area of Science:

  • Pediatrics
  • Neuroscience
  • Biochemistry

Background:

  • Current infant iron deficiency (ID) screening at one year of age is insufficient.
  • It fails to detect preanemic ID and prevent later neurocognitive deficits.

Purpose of the Study:

  • Identify biomarkers for iron-related metabolic alterations in serum and brain.
  • Assess the sensitivity of conventional iron and heme indices in predicting brain metabolic dysfunction in infantile ID using a nonhuman primate model.

Main Methods:

  • Analyzed serum iron and RBC indices, along with serum and CSF metabolomic profiles in iron-sufficient and iron-deficient rhesus infants at 2 and 4 months.
  • Compared metabolic profiles and iron indices between groups.

Main Results:

  • Reticulocyte hemoglobin (RET-He) was lower in the ID group at 2 weeks.
  • Serum and CSF metabolomic profiles differed significantly between iron-sufficient and iron-deficient infants by 2 months.
  • Key metabolites, homostachydrine and stachydrine, were significantly lower in the ID group's serum and CSF.
  • RET-He and serum iron indices at 2 months correlated with altered CSF metabolic profiles at 4 months.

Conclusions:

  • Preanemic ID in infants is linked to serum and CSF metabolic alterations.
  • RET-He emerged as a predictor of abnormal CSF metabolic profiles, comparable to serum iron indices.
  • Homostachydrine and stachydrine in serum and CSF show potential as early biomarkers for brain metabolic dysfunction in infantile ID.
Abstract

Related Concept Videos